Please try another search
Aerocrine AB (publ), together with its subsidiaries, operates as a medical technology company primarily in Europe, the United States, North America, Asia, and the Oceania. The company offers NIOX MINO and NIOX VERO devices for checking inflammatory conditions in airways, as well as enhancing diagnosis, treatment, and follow-up of people with asthma. It serves research and pharmaceutical development companies, specialist doctors, outpatient and primary care clinics, and patients. The company was founded in 1997 and is headquartered in Solna, Sweden. As of June 26, 2015, Aerocrine AB operates as a subsidiary of Circassia Limited.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review